GlucoTrack, Inc. (GCTK) stock forecast & analysis
1.39
NasdaqCM · USDDelayed by 15 minutes
Unchanged: +0.00, +0.0%
1 analysis
Latest analysis: · verdict locked
- Open
- 2.00
- Previous close
- 1.39
- Day range
- 1.07 – 2.24
- 52-week range
- 0.5000 – 207.00
- Volume (shares)
- 4.25M
- Net assets
- Not available
- Expense ratio
- Not available
- Shares outstanding
- 1.18M
- P/E ratio
- Not available
- Dividend yield
- 0.00%
- Beta
- 0.73
- Market cap
- 1.65M
Market Scanner’s AI analysis of GlucoTrack, Inc. (GCTK), updated October 2026: GlucoTrack's reverse stock split and financing efforts contrasted with increasing net losses and negative equity.
This page is the public summary. A signed-in user can run a fresh five-stage AI analysis of GlucoTrack, Inc. (GCTK) and read the full verdict with the bull and bear debate behind it — using Market Scanner tokens, or their own OpenAI or Anthropic key.
Summary
GlucoTrack's reverse stock split and financing efforts contrasted with increasing net losses and negative equity.
Recent analyses for GlucoTrack, Inc. (GCTK) covered its market performance, financial health, and strategic initiatives. The reports detailed the company's trading below key moving averages and approaching oversold RSI levels, alongside strong MFI readings. Financials indicated increasing net losses and negative shareholder equity, while news highlighted a reverse stock split, recent financings, and Nasdaq equity compliance.
GCTK news & sentiment
News coverage highlighted a strategic shift for GlucoTrack, Inc. with a reverse stock split and recent financings, alongside achieving equity compliance. Social media discussion was not covered in the provided notes.
GCTK technical picture
The stock traded significantly below its key moving averages, with short-term momentum also negative. The Relative Strength Index (RSI) approached oversold territory, while the Money Flow Index (MFI) indicated strong buying pressure. MACD confirmed bearish momentum, though it appeared to be waning, and Bollinger Bands showed the price below the lower band.
Fundamentals
The company has demonstrated a trend of increasing net losses annually and quarterly, alongside deteriorating financial health indicated by negative shareholder equity. Liabilities have surpassed assets, resulting in a deficit. The analysis covered the company's market capitalization and stock price in the context of these financial trends.
Factors discussed — upside
- High Money Flow Index (MFI) indicating strong buying pressure.
- Relative Strength Index (RSI) approaching oversold territory.
- Achieved Nasdaq equity compliance and a key compliance milestone.
- Secured $3 million public offering and $5.5 million financing.
Factors discussed — risks
- Stock trading significantly below 50-day and 200-day SMAs.
- Increasing net losses in annual and quarterly reports.
- Negative shareholder equity with liabilities exceeding assets.
- MACD confirming bearish momentum.
- Technical indicators
- Financial performance
- Corporate actions
- Regulatory compliance
Summary updated .
GCTK technical indicators
Common technical indicators for GCTK, computed from its daily closing prices.
| Indicator | Value | Reading |
|---|---|---|
| 50-day simple moving average | 4.23 | Price below |
| 10-day exponential moving average | 1.46 | Price below |
| Relative strength index (14-day) | 31.86 | Neutral |
| MACD line (12/26/9) | -0.8491 | Above its signal line |
| Bollinger bands (20-day, 2σ) | 0.74 – 2.66 | Price inside the bands |
Analyses
Recent GCTK.US analyses are locked — sign in to read them or generate a fresh one.
Locked
Unlock in the library — 1 newer report
Sign in to unlock the 2026-10-27 GCTK.US analysis
Get the verdict — free
Frequently asked questions
- What is the bull case for GlucoTrack, Inc.?
- The bull case for GlucoTrack, Inc. centers on strong buying pressure indicated by a high Money Flow Index and the stock approaching oversold RSI levels. Recent corporate actions, including achieving Nasdaq equity compliance and securing significant public and private financing, also support the upside case.
- What are the risks for GlucoTrack, Inc.?
- Risks for GlucoTrack, Inc. include its stock trading significantly below key moving averages and confirmed bearish momentum. The company's financial health is a concern, with increasing net losses and negative shareholder equity, alongside liabilities exceeding assets.
- Is GlucoTrack, Inc. bullish or bearish?
- Recent AI analyses of GlucoTrack, Inc. examined factors on both sides. Discussed upside: The bull case for GlucoTrack, Inc. centers on strong buying pressure indicated by a high Money Flow Index and the stock approaching oversold RSI levels. Recent corporate actions, including achieving Nasdaq equity compliance and securing significant public and private financing, also support the upside case. Discussed risks: Risks for GlucoTrack, Inc. include its stock trading significantly below key moving averages and confirmed bearish momentum. The company's financial health is a concern, with increasing net losses and negative shareholder equity, alongside liabilities exceeding assets. These are descriptive observations, not a recommendation.
- What is the latest sentiment on GlucoTrack, Inc.?
- News coverage highlighted a strategic shift for GlucoTrack, Inc. with a reverse stock split and recent financings, alongside achieving equity compliance. Social media discussion was not covered in the provided notes.
- How does Market Scanner analyse GlucoTrack, Inc.?
- Every analysis of GlucoTrack, Inc. runs the same five stages: four analysts read the market independently, a bull and a bear debate what they found, one agent turns the ruling into a position, three risk perspectives stress-test it, and a final agent writes the report. Market Scanner publishes what each stage does, with figures computed from the analyses on the platform rather than written in by hand.Read the methodology
What is the bull case for GlucoTrack, Inc.?
The bull case for GlucoTrack, Inc. centers on strong buying pressure indicated by a high Money Flow Index and the stock approaching oversold RSI levels. Recent corporate actions, including achieving Nasdaq equity compliance and securing significant public and private financing, also support the upside case.
What are the risks for GlucoTrack, Inc.?
Risks for GlucoTrack, Inc. include its stock trading significantly below key moving averages and confirmed bearish momentum. The company's financial health is a concern, with increasing net losses and negative shareholder equity, alongside liabilities exceeding assets.
Is GlucoTrack, Inc. bullish or bearish?
Recent AI analyses of GlucoTrack, Inc. examined factors on both sides. Discussed upside: The bull case for GlucoTrack, Inc. centers on strong buying pressure indicated by a high Money Flow Index and the stock approaching oversold RSI levels. Recent corporate actions, including achieving Nasdaq equity compliance and securing significant public and private financing, also support the upside case. Discussed risks: Risks for GlucoTrack, Inc. include its stock trading significantly below key moving averages and confirmed bearish momentum. The company's financial health is a concern, with increasing net losses and negative shareholder equity, alongside liabilities exceeding assets. These are descriptive observations, not a recommendation.
What is the latest sentiment on GlucoTrack, Inc.?
News coverage highlighted a strategic shift for GlucoTrack, Inc. with a reverse stock split and recent financings, alongside achieving equity compliance. Social media discussion was not covered in the provided notes.
How does Market Scanner analyse GlucoTrack, Inc.?
Every analysis of GlucoTrack, Inc. runs the same five stages: four analysts read the market independently, a bull and a bear debate what they found, one agent turns the ruling into a position, three risk perspectives stress-test it, and a final agent writes the report. Market Scanner publishes what each stage does, with figures computed from the analyses on the platform rather than written in by hand.
Read the methodology- Bundles used
- gemini-low-v2
Run a fresh GCTK.US analysis
Configure the ticker, model bundle and debate depth here — you only sign in at the end, and everything you picked comes with you.